资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医讯达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
#CRT#
60篇内容 | 2741人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=4310528ea7, topicName=CRT, introduction=CRT, content=null, image=null, comments=60, allHits=2741, url=https://h5.medsci.cn/topic?id=5287, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=599, tagList=[TagDto(tagId=599, tagName=CRT)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1341474, encodeId=8a6513414e409, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=JAMA Oncol:nCRT和病理学完全应答的直肠癌患者,AC能否改善OS?, objectType=article, longId=146620, objectId=d2ab146620f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2ab146620f1, replyNumber=0, likeNumber=81, createdTime=2018-08-16, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2ab146620f1, moduleTitle=JAMA Oncol:nCRT和病理学完全应答的直肠癌患者,AC能否改善OS?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2ab146620f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341473, encodeId=a90e13414e32b, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=安徽省立医院CRT应用经验:左心室限制性充盈冠心病患者疗效差, objectType=article, longId=125553, objectId=25261255530f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25261255530f, replyNumber=0, likeNumber=67, createdTime=2018-01-06, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25261255530f, moduleTitle=安徽省立医院CRT应用经验:左心室限制性充盈冠心病患者疗效差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25261255530f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341472, encodeId=89ad13414e2bd, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=CRT-D术中突发心衰 患者九死一生多亏……, objectType=article, longId=123440, objectId=b798123440e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b798123440e4, replyNumber=0, likeNumber=73, createdTime=2017-12-16, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b798123440e4, moduleTitle=CRT-D术中突发心衰 患者九死一生多亏……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b798123440e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341471, encodeId=669b13414e13f, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=Cell Mol Life Sci:蛋白激酶D抑制剂CRT0066101通过在G2 / M阻断细胞周期抑制膀胱癌细胞体外和异种移植物的生长。, objectType=article, longId=119020, objectId=65a81190201d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65a81190201d, replyNumber=0, likeNumber=38, createdTime=2017-11-08, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65a81190201d, moduleTitle=Cell Mol Life Sci:蛋白激酶D抑制剂CRT0066101通过在G2 / M阻断细胞周期抑制膀胱癌细胞体外和异种移植物的生长。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65a81190201d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341470, encodeId=796013414e07b, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=Cell:挑战原有观点:ESCRT样程序性细胞坏死, objectType=article, longId=96397, objectId=d4ac9639efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4ac9639efa, replyNumber=0, likeNumber=114, createdTime=2017-04-20, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4ac9639efa, moduleTitle=Cell:挑战原有观点:ESCRT样程序性细胞坏死, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4ac9639efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341469, encodeId=0635134146959, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=SCRT:胎盘间充质干细胞治疗缺血性疾病又有新发现, objectType=article, longId=69373, objectId=e2bf693e35e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2bf693e35e, replyNumber=0, likeNumber=0, createdTime=2016-05-30, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2bf693e35e, moduleTitle=SCRT:胎盘间充质干细胞治疗缺血性疾病又有新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2bf693e35e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341468, encodeId=4cc113414682a, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=JACC:中度至重度CKD心衰患者中,接受带有除颤器的CRT治疗可显著降低心衰入院和死亡的概率, objectType=article, longId=60529, objectId=a908605291b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a908605291b, replyNumber=0, likeNumber=63, createdTime=2015-12-13, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a908605291b, moduleTitle=JACC:中度至重度CKD心衰患者中,接受带有除颤器的CRT治疗可显著降低心衰入院和死亡的概率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a908605291b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341467, encodeId=f73e134146e47, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=ESC 2015:CRT-D疗效未必优于CRT-P(CeRtiTuDe队列研究), objectType=article, longId=55892, objectId=9a84558921a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a84558921a, replyNumber=0, likeNumber=65, createdTime=2015-09-10, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a84558921a, moduleTitle=ESC 2015:CRT-D疗效未必优于CRT-P(CeRtiTuDe队列研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a84558921a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341466, encodeId=e290134146660, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=BCRT:糖尿病女性更容易患进展期乳腺癌!, objectType=article, longId=48603, objectId=5f0948603a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f0948603a4, replyNumber=0, likeNumber=66, createdTime=2015-03-27, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f0948603a4, moduleTitle=BCRT:糖尿病女性更容易患进展期乳腺癌!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f0948603a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341465, encodeId=6e321341465e8, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=Diabetes Care:hs-CRP可预测糖尿病肾病发生风险(DDCRT7注册研究), objectType=article, longId=40072, objectId=a679400e25b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a679400e25b, replyNumber=0, likeNumber=56, createdTime=2014-09-10, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a679400e25b, moduleTitle=Diabetes Care:hs-CRP可预测糖尿病肾病发生风险(DDCRT7注册研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a679400e25b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341464, encodeId=c25113414642a, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=PNAS:抑制CRTC1/MAML2基因链接蛋白有助于口腔癌治疗, objectType=article, longId=38542, objectId=127f38542f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=127f38542f3, replyNumber=0, likeNumber=64, createdTime=2014-08-03, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=127f38542f3, moduleTitle=PNAS:抑制CRTC1/MAML2基因链接蛋白有助于口腔癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=127f38542f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341463, encodeId=70f51341463aa, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=李广平:ICD/CRT-P/CRT-D植入指征的变化与临床个体化, objectType=article, longId=38518, objectId=11d83851880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11d83851880, replyNumber=0, likeNumber=80, createdTime=2014-08-02, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11d83851880, moduleTitle=李广平:ICD/CRT-P/CRT-D植入指征的变化与临床个体化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11d83851880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341462, encodeId=6d5613414622a, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=JAMA Intern Med:女性接受CRT-D治疗的适应证应扩大?, objectType=article, longId=37251, objectId=98913e2517c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98913e2517c, replyNumber=0, likeNumber=130, createdTime=2014-07-03, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98913e2517c, moduleTitle=JAMA Intern Med:女性接受CRT-D治疗的适应证应扩大?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98913e2517c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341461, encodeId=e27813414613f, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=OCC 2014:合并房颤心衰患者的治疗:CRT或消融?, objectType=article, longId=36180, objectId=253836180d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=253836180d0, replyNumber=0, likeNumber=105, createdTime=2014-06-11, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=253836180d0, moduleTitle=OCC 2014:合并房颤心衰患者的治疗:CRT或消融?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=253836180d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341460, encodeId=ffae1341460ed, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=ASCO 2014:局部晚期NSCLC每周三次紫杉醇同步放化疗(CCRT)优于每周一次, objectType=article, longId=35636, objectId=e8bc35636c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8bc35636c5, replyNumber=0, likeNumber=70, createdTime=2014-06-02, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8bc35636c5, moduleTitle=ASCO 2014:局部晚期NSCLC每周三次紫杉醇同步放化疗(CCRT)优于每周一次, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8bc35636c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341459, encodeId=08d3134145994, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=Ann Intern Med:治疗左室射血分数降低和QRS间期延长的老年患者 CRT-D优于ICD, objectType=article, longId=34534, objectId=47fa3453456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47fa3453456, replyNumber=0, likeNumber=53, createdTime=2014-05-11, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47fa3453456, moduleTitle=Ann Intern Med:治疗左室射血分数降低和QRS间期延长的老年患者 CRT-D优于ICD, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47fa3453456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341458, encodeId=67c4134145850, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=NEJM:CRT-D有益于合并LBBB轻度心衰患者长期生存(MADIT-CRT), objectType=article, longId=34432, objectId=43b834432d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43b834432d2, replyNumber=0, likeNumber=74, createdTime=2014-05-09, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43b834432d2, moduleTitle=NEJM:CRT-D有益于合并LBBB轻度心衰患者长期生存(MADIT-CRT), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43b834432d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341457, encodeId=7c27134145e1d, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=FDA扩美敦力CRT适应证, objectType=article, longId=33444, objectId=1937334448f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1937334448f, replyNumber=0, likeNumber=89, createdTime=2014-04-17, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1937334448f, moduleTitle=FDA扩美敦力CRT适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1937334448f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341456, encodeId=02411341456ed, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=ACC 2014:CRT-D可降充血性心衰事件发生率及死亡率, objectType=article, longId=33163, objectId=50f433163f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50f433163f0, replyNumber=0, likeNumber=94, createdTime=2014-04-12, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50f433163f0, moduleTitle=ACC 2014:CRT-D可降充血性心衰事件发生率及死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50f433163f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341455, encodeId=a143134145551, content=<a href='/topic/show?id=4310528ea7' target=_blank style='color:#2F92EE;'>#CRT#</a>, objectTitle=Heart:CRT-D未产生额外生存获益, objectType=article, longId=32922, objectId=ca2c32922b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca2c32922b1, replyNumber=0, likeNumber=62, createdTime=2014-04-06, rootId=0, userName=41514487@qq.com, userId=c6a52500178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca2c32922b1, moduleTitle=Heart:CRT-D未产生额外生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca2c32922b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
CRT
2020-05-29
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
JAMA Oncol:nCRT和病理学完全应答的直肠癌患者,AC能否改善OS?
81
0
2018-08-16
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
安徽省立医院CRT应用经验:左心室限制性充盈冠心病患者疗效差
67
0
2018-01-06
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
CRT-D术中突发心衰 患者九死一生多亏……
73
0
2017-12-16
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
Cell Mol Life Sci:蛋白激酶D抑制剂CRT0066101通过在G2 / M阻断细胞周期抑制膀胱癌细胞体外和异种移植物的生长。
38
0
2017-11-08
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
Cell:挑战原有观点:ESCRT样程序性细胞坏死
114
0
2017-04-20
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
SCRT:胎盘间充质干细胞治疗缺血性疾病又有新发现
0
0
2016-05-30
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
JACC:中度至重度CKD心衰患者中,接受带有除颤器的CRT治疗可显著降低心衰入院和死亡的概率
63
0
2015-12-13
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
ESC 2015:CRT-D疗效未必优于CRT-P(CeRtiTuDe队列研究)
65
0
2015-09-10
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
BCRT:糖尿病女性更容易患进展期乳腺癌!
66
0
2015-03-27
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
Diabetes Care:hs-CRP可预测糖尿病肾病发生风险(DDCRT7注册研究)
56
0
2014-09-10
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
PNAS:抑制CRTC1/MAML2基因链接蛋白有助于口腔癌治疗
64
0
2014-08-03
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
李广平:ICD/CRT-P/CRT-D植入指征的变化与临床个体化
80
0
2014-08-02
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
JAMA Intern Med:女性接受CRT-D治疗的适应证应扩大?
130
0
2014-07-03
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
OCC 2014:合并房颤心衰患者的治疗:CRT或消融?
105
0
2014-06-11
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
ASCO 2014:局部晚期NSCLC每周三次紫杉醇同步放化疗(CCRT)优于每周一次
70
0
2014-06-02
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
Ann Intern Med:治疗左室射血分数降低和QRS间期延长的老年患者 CRT-D优于ICD
53
0
2014-05-11
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
NEJM:CRT-D有益于合并LBBB轻度心衰患者长期生存(MADIT-CRT)
74
0
2014-05-09
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
FDA扩美敦力CRT适应证
89
0
2014-04-17
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
ACC 2014:CRT-D可降充血性心衰事件发生率及死亡率
94
0
2014-04-12
回复
41514487@qq.com
(审核中...)
关注
已关注
前往app查看评论内容
#CRT#
Heart:CRT-D未产生额外生存获益
62
0
2014-04-06
回复
共61条
首页
上一页
下一页
尾页
页码:
2
/4页
20条/页
扫描二维码下载梅斯医学APP
科室
订阅+
更多科室
工具
服务